๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Optical spectroscopic studies of the antitumor drug 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione(mitoxantrone)

โœ Scribed by Lee, B. S.; Dutta, Prabir K.

Book ID
120165098
Publisher
American Chemical Society
Year
1989
Tongue
English
Weight
1000 KB
Volume
93
Category
Article
ISSN
0022-3654

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Pharmacological disposition of 1,4-dihyd
Pharmacological disposition of 1,4-dihydroxy-5-8-bis[[2[(2-hydroxyethal)amino] ethyl]amino]-9,10-anthracenedione dihydrochloride in the dog
โœ Katherine Lu; Niramol Savaraj; Ti Li Loo ๐Ÿ“‚ Article ๐Ÿ“… 1984 ๐Ÿ› Springer ๐ŸŒ English โš– 328 KB

D HA Q, a new antitumor agent, has been selected for clinical trial on the basis of its activity against a number of transplantable rodent tumors. In anticipation of the clinical trial of this agent, the pharmacology of DHAQ was studied in beagles by high-pressure liquid chromatographic and radioche

Structure-activity relationship study of
Structure-activity relationship study of anthraquinones: 1, 4-dihydroxy-5, 8-bis[[2-(2-hydroxyethoxy)ethyl]amino]-9, 10-anthracenedione, an analog of an established antineoplastic agent
โœ Robert K. Y. Zee-Cheng; C. C. Cheng ๐Ÿ“‚ Article ๐Ÿ“… 1982 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 188 KB

An oxygen analog of the antineoplastic anthraquinone, 1,4-dihydroxy-5,8-bis[ [2-(2-hydroxyethyl)amino]ethyl)amino -9,lO -anthracenedione, was synthesized. This compound, 1,4-dihydroxy-5,8bis[ [2-(2-hydroxyethoxy)ethyI]amino] -9,10-anthracenedione, was found to be inactive against P-388 lymphocytic l